Great point. Despite the fact that RXMD has had amazing revenues (on track now for 40 mil per year) and growth over the last 3 - 4 years the share price, with the exception of a couple of spikes, has lagged in the .03 - .05 cent range for that time. This IMO is due to the need for the company to obtain financing through convertibles and because the OTC simply is a swamp.
If RXMD moves up to a different exchange, it will be able to seek more conventional financing and trading of the stock will be more stable. I've been here for 5 years and frankly I'm tired of this stock being manipulated and deprived of realizing its fair value.
Market Data 
Markets 
